|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PubMed |
10075646 |
The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of |
1.71 KB |
2015-11-03 |
|
24 |
|
0 |
2021-07-12
|
| PubMed |
10545183 |
Amyloidogenic function of the Alzheimer's disease-associated presenilin 1 in the absence of endoprot |
1.77 KB |
2015-11-21 |
|
3 |
|
0 |
2021-07-12
|
| PubMed |
10899436 |
Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
Alzhei |
1.32 KB |
2015-11-15 |
|
15 |
|
1 |
2021-07-12
|
| PubMed |
11447840 |
Tau gene mutations and neurodegeneration.
Abundant neurofibrillary lesions made of the microtubule-a |
1.75 KB |
2015-11-17 |
|
3 |
|
1 |
2021-07-12
|
| PubMed |
11906199 |
Generation of amyloid beta protein from a presenilin-1 and betaAPP complex.
Presenilin-1 (PS1) is a |
1.03 KB |
2015-11-22 |
|
1 |
|
1 |
2021-07-12
|
| PubMed |
11959461 |
FAD-linked mutations in presenilin 1 alter the length of Abeta peptides derived from betaAPP transme |
1.45 KB |
2015-11-22 |
|
11 |
|
1 |
2021-07-12
|
| PubMed |
15006708 |
Fibroblasts from FAD-linked presenilin 1 mutations display a normal unfolded protein response but ov |
1.12 KB |
2015-11-18 |
|
4 |
|
2 |
2021-07-12
|
| PubMed |
15192323 |
APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-catenin.
Alzheimer's |
861 Bytes |
2015-11-22 |
|
2 |
|
9 |
2021-07-12
|
| PubMed |
15192701 |
PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutati |
1.4 KB |
2015-11-19 |
|
3 |
|
4 |
2021-07-12
|
| PubMed |
15992373 |
Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid p |
1.51 KB |
2015-11-19 |
|
3 |
|
8 |
2021-07-12
|
